Evaluation of bovine spongiform encephalopathies (BSE) - risk via the use of materials of bovine origin in or during the manufacture of vaccines - Scientific guideline

HumanScientific guidelines

Swedish is available via eTranslation, the European Commission's machine translation service.

Translate to Swedish | Important information about machine translation

This document aims to assess the risk of the use of materials of bovine origin in or during the manufacture of vaccines.

Keywords: Bovine spongiform encephalopathies (BSE), risk assessment, materials of bovine origin, vaccines

Current version

Public statement on the evaluation of bovine spongiform encephalopathies (BSE) - risk via the use of materials of bovine origin in or during the manufacture of vaccines

Adopted Reference Number: EMEA/CPMP/BWP/476/01 Legal effective date:

English (EN) (21.44 KB - PDF)

Först publicerad: Senast uppdaterad:
Visa

Share this page